Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guardian Pharmacy ServicesGRDN +1.20%42 Equity-to-Asset is 0.55 as of Jun. 2026, which is 206% above its 10-year median of 0.18. GuruFocus rates GRDN with a GF Score™ of 42/100. Among 684 Healthcare Providers & Services companies, Guardian Pharmacy Services ranks better than 57.46% on this metric.
The historical rank and industry rank for Guardian Pharmacy Services's Equity-to-Asset or its related term are showing as below:
GRDN'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.06 Med: 0.18 Max: 0.55
Current: 0.55
During the past 8 years, the highest Equity to Asset Ratio of Guardian Pharmacy Services was 0.55. The lowest was 0.06. And the median was 0.18.
GRDN's Equity-to-Asset is ranked better than 57.46% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs GRDN: 0.55
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Guardian Pharmacy Services Equity-to-Asset Related Terms
Guardian Pharmacy Services Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GRDN vs MD, ADUS, AVAH: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Guardian Pharmacy Services's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guardian Pharmacy Services Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guardian Pharmacy Services's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Guardian Pharmacy Services's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Guardian Pharmacy Services's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardian Pharmacy Services (GRDN) has a Equity-to-Asset of 0.55 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Guardian Pharmacy Services and its competitors. This is 206% above median its historical median of 0.18. Over the past decade, Guardian Pharmacy Services' Equity-to-Asset has ranged from 0.06 to 0.55. According to the industry distribution chart, Guardian Pharmacy Services ranks #291 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 42.5%.
Is Guardian Pharmacy Services' Equity-to-Asset too high?
Guardian Pharmacy Services' current Equity-to-Asset of 0.55 is 206% above median its 10-year median of 0.18. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 0.55. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Guardian Pharmacy Services' value of 0.55 is 14.6% above this industry median. Based on the distribution chart, Guardian Pharmacy Services ranks #291 out of 684 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' Equity-to-Asset compare to MD and ADUS?
According to the Healthcare Providers & Services industry distribution chart, Guardian Pharmacy Services ranks #291 out of 684 companies for Equity-to-Asset. This puts Guardian Pharmacy Services in the upper half of its industry. The industry median Equity-to-Asset is 0.48. Guardian Pharmacy Services' value of 0.55 is 14.6% above this benchmark. Historically, Guardian Pharmacy Services' own Equity-to-Asset has ranged from 0.06 to 0.55 over the past decade. While the company's 10-year median is 0.18 vs. the industry median of 0.48, Guardian Pharmacy Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guardian Pharmacy Services's current Equity-to-Asset of 0.55 is 14.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Guardian Pharmacy Services and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guardian Pharmacy Services's current Equity-to-Asset is 0.55, which is 206% above median its own 10-year median of 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current Equity-to-Asset of 0.55. The current Equity-to-Asset is 0.55, which is 206% above median its 10-year median of 0.18 and 14.6% above the Healthcare Providers & Services industry median of 0.48. Guardian Pharmacy Services' overall GF Score™ is 42/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current Equity-to-Asset is 0.55 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score
Get the complete analysis for GRDN
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRDN has been successfully added to your 
